Could a diabetes drug curb alcohol cravings? new study says maybe.
NCT ID NCT05891587
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether semaglutide, a drug used for diabetes and weight loss, can safely reduce alcohol drinking in people with alcohol use disorder. 80 adults took either semaglutide or a placebo, and researchers tracked how much they drank over several weeks. The goal was to see if the drug could help control drinking habits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
OSU Biomedical Imaging Center
Tulsa, Oklahoma, 74136, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a brain zapping headset curb relapse in addiction?
- Can a smartphone app tame Alcohol-Related liver disease?
- Calm in a room: can sensory therapy soothe the mind?
- Can a brief alcohol intervention improve mental health treatment?
- Smartphone support for sobriety: a trial tests digital tools in black communities
- Emergency room could be the starting point for alcohol addiction treatment